PURPOSE
Colorectal cancer metastatic to the liver, when technically feasible, is resected with a moderate chance of cure. The most common site of failure after resection is in the remaining liver. To enhance survival, chemotherapy has been delivered directly to the liver postresection via the hepatic artery. This study was designed to assess the effect of posthepatic resection, hepatic artery chemotherapy on overall survival.
METHODS
Trials were sought in Medline, the Cochrane Controlled Trial Register, The Cochrane Hepatobiliary Group Trials Register, and through contact of trial authors and reference lists using key words: colorectal, cancer, hepatic metastases, hepatic artery, chemotherapy, and randomized. Trials were chosen in which patients having resection of colorectal cancer metastatic to the liver were randomized to hepatic artery chemotherapy or any alternative treatment. Survival data were obtained principally from abstraction from survival curves in published studies using the method of Parmar to calculate a study-specific, log-hazard ratio and then combined-effect, log-hazard ratio, as well as a combined Kaplan-Meier survival probability curve.
RESULTS
Overall survival at five years in the hepatic artery group was 45 percent and 40 percent in the control group. Forty-three individuals developed recurrent liver metastases in the hepatic artery chemotherapy group, and 97 developed liver recurrence in the control group. However, no significant advantage was found in the meta-analysis for hepatic artery chemotherapy measuring overall survival and calculating survival based on “intention to treat” (log-hazard ratio = 0.0848, favoring the control group; 95 percent confidence interval = ±0.2037). Adverse events related to hepatic artery therapy were common, including five therapy-related deaths.
CONCLUSIONS
Although recurrence in the remaining liver happened less frequently in the hepatic artery chemotherapy group, overall survival was not improved. The log-hazard ratio even favored the control group, although not significantly. This added intervention for the treatment of metastatic colorectal cancer cannot be recommended at this time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
F Bozzetti R Doci P Bignami A Morabito L Gennari (1987) ArticleTitlePatterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach Ann Surg 205 264–70
M Lorenz HH Mueller H Schramm et al. (1998) ArticleTitleRandomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for live metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg 228 756–62
MM Kemeny S Adak B Gray et al. (2002) ArticleTitleCombined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study J Clin Oncol 20 1499–505
N Kemeny Y Huang AM Cohen et al. (1999) ArticleTitleHepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 2039–48
C Rudroff A Altendorgf-Hoffmann R Stangl J Scheele (1999) ArticleTitleProspective randomized trial on adjuvant hepatic artery infusion chemotherapy after R0 resection of colorectal liver metastases Langenbecks Arch Surg 384 243–9
T Tono Y Hasuike H Ohzato Y Takasuka N Kikkawa (2000) ArticleTitleLimited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases Cancer 88 1549–56
LD Wagman MM Kemeny L Leong et al. (1990) ArticleTitleA prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver J Clin Oncol 8 1885–93
NJ Lygidakis J Pothoulakis AE Konstantinidou H Spanos (1995) ArticleTitleHepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study Anticancer Res 15 543–50
MK Parmar V Torri L Stewart (1998) ArticleTitleExtracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815–34
D Petitti (1994) Meta-analysis, decision analysis and cost-effectiveness analysis Oxford University Press New York
JPT Higgins SG Thompson JJ Deeks DG Altman (2003) ArticleTitleMeasuring inconsistency in meta-analysis BMJ 327 557–60
Freels S. Letter. Stat Med (in press).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nelson, R., Freels, S. A Systematic Review of Hepatic Artery Chemotherapy After Hepatic Resection of Colorectal Cancer Metastatic to the Liver. Dis Colon Rectum 47, 739–745 (2004). https://doi.org/10.1007/s10350-003-0113-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-003-0113-7